CollPlant Biotechnologies Ltd.
CLGN
$1.47
-$0.03-2.00%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | |||
|---|---|---|---|---|---|
| Net Income | -0.36% | 10.54% | -7.13% | ||
| Total Depreciation and Amortization | -6.79% | -1.41% | 4.41% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 47.47% | 13.70% | -42.43% | ||
| Change in Net Operating Assets | -339.27% | -85.43% | -83.46% | ||
| Cash from Operations | -20.75% | -38.72% | -134.61% | ||
| Capital Expenditure | -146.34% | 64.19% | 5.76% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -215.85% | 77.96% | -53.09% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -100.00% | -- | -100.00% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -100.00% | -- | -100.00% | ||
| Foreign Exchange rate Adjustments | 4.07% | -161.81% | 248.51% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -24.82% | -36.97% | -138.07% | ||